Yahoo Finance

Folate Receptor Alpha (FRa) Targeted Therapy Competitor Analysis Report 2025: Next Generation Cell Therapy Modalities and Radiopharmaceuticals are Advancing in the Pipeline

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Folate Receptor alpha (FRa) Targeted Therapy: a Competitor Analysis" report has been added to ResearchAndMarkets.com's offering. This competitive ...
The American Journal of Managed Care

FRα Biomarker Testing in Patients With Ovarian Cancer

A panelist discusses how folate receptor alpha (FRα) expression testing plays a crucial role in determining eligibility for mirvetuximab soravtansine (an antibody-drug conjugate therapy), emphasizing ...
Nasdaq

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting

INDIANAPOLIS, June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) ...
Mena FN

Folate Receptor Alpha (Fra) Targeted Therapy Competitor Analysis Report 2025: Next Generation Cell Therapy Modalities And Radiopharmaceuticals Are Advancing In The Pipeline

(MENAFN- GlobeNewsWire - Nasdaq) Folate receptor alpha (FRα) presents strong market opportunities as a validated target, especially in ovarian and lung adenocarcinomas. Potential growth lies in ...